tykhr
sign in
free sign up
Aerovate Therapeutics Inc
Biotechnology
Healthcare
AVTE
28.86 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
2.50
52 week high
24.62
high
2.58
52 week low
1.41
low
2.47
growth
-85.73 %
previous Close
2.51
P/E ratio
market cap
73.14 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-16.24 M
34.46 %
eps
0.00 %
34.88 %
eps surprise
-229.41 %
net profit margin
-1623700000.00 %
0.00 %
operating incoming
-17.41 M
33.46 %
net change in cash
46.00 K
-99.79 %
cash on hand
31.12 M
0.15 %
cost of revenue
0.00 %
top